|
"hsu ta"的相關文件
顯示項目 66-75 / 92 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2010-12-01 |
吲哚化合物
|
Hsieh, HP;Mahindroo, N;Hsu, TA;Huang, CF;Chen, X;Chao, YS |
| 國家衛生研究院 |
2010-08-21 |
硫尿化合物及抑制C型肝炎病毒感染之方法
|
Chern, JH;Hsu, TA;Kang, IJ;Wang, LW;Lee, CC;Lee, YC;Chao, YS |
| 國家衛生研究院 |
2010-08 |
Lead optimization of furanopyrimidine Aurora kinase inhibitors: Development of in vivo active agents in tumor xenograft models
|
Hsieh, HP;Chu, CY;Coumar, MS;Lin, WH;Chen, CT;Hsu, TA;Wu, SY;Chao, YS |
| 國家衛生研究院 |
2009-11-01 |
Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors
|
Kang, IJ;Wang, LW;Hsu, SJ;Lee, CC;Lee, YC;Wu, YS;Yueh, A;Wang, JC;Hsu, TA;Chao, YS;Chern, JH |
| 國家衛生研究院 |
2009-08-01 |
Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors
|
Kang, IJ;Wang, LW;Hsu, SJ;Lee, CC;Lee, YC;Wu, YS;Hsu, TA;Yueh, A;Chao, YS;Chern, JH |
| 國家衛生研究院 |
2009-06-09 |
Treatment of coronavirus infection
|
Hsu, TA;Hsieh, HP;Chao, YS;Chen, CM;Jan, JT;Liu, HW |
| 國家衛生研究院 |
2009-04-01 |
Design, synthesis, and anti-HCV activity of thiourea compounds
|
Kang, IJ;Wang, LW;Lee, CC;Lee, YC;Chao, YS;Hsu, TA;Chern, JH |
| 國家衛生研究院 |
2009-03 |
Discovery and development of novel furano-pyrimidine analogs as Aurora kinase inhibitors
|
Hsieh, HP;Coumar, MS;Lin, CW;Reddy, GR;Tsai, MT;Lin, WH;Hsu, TA;Wu, SY |
| 國家衛生研究院 |
2008-12-11 |
吲哚化合物
|
Hsieh, HP;Mahindroo, N;Hsu, TA;Huang, CF;Chen, X;Chao, YS |
| 國家衛生研究院 |
2008-11-11 |
Indole compounds
|
Hsieh, HP;Mahindroo, NH;Hsu, TA;Huang, CF;Chen, X;Chao, YS |
顯示項目 66-75 / 92 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
